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Background: Hydrocelectomy is practiced as the gold standard technique for the treatment of hydrocele
worldwide. Aspiration and sclerotherapy is cheap, less invasive and safe compared to hydrocelectomy.
However, the outcomes are inconsistent because of lack of uniformity in methods and sclerosing agents
used.
Materials and methods: This was a randomized controlled study conducted in a university hospital for
a period of one year. Sixty symptomatic adult males without fertility concern or coexisting scrotal
pathology were enrolled. Aspiration and sclerotherapy and hydrocelectomy were performed in 30 each.
Primary outcome measures: incidence of complications, loss of working days, cost involved, recurrence
rate and patient’s satisfaction. Patients were followed up till 6 months after the procedures.
Results: Eight patients (26.7%) after hydrocelectomy developed fever which was signiﬁcantly more
(p< 0.05) than 2 patients (6.7%) following sclerotherapy. Four patients (14%) with hydrocelectomy had
infection (p< 0.05). The incidence of pain and haematocele between the two groups were comparable.
Nine patients (34.6%) after sclerotherapy developed recurrence at 3 months. All patients developed
recurrence after repeat aspiration and sclerotherapy. The level of satisfaction was more in hydro-
celectomy 19 (95%) versus 13 (61.9%) patients in sclerotherapy (p< 0.05). The cost involved was ﬁvefold
and the loss of working days sevenfold in hydrocelectomy (p< 0.01) as compared to sclerotherapy.
Conclusion: Although aspiration and sclerotherapy had less complications, morbidity and was cheaper, it
had lower success rate and less patient’s satisfaction than hydrocelectomy.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Primary vaginal hydrocele is a benign scrotal condition, result-
ing from abnormal ﬂuid collection between the layers of tunica
vaginalis of testis. Though, majority of hydroceles pose little clinical
consequences, treatment should be considered if the hydrocele is
large or symptomatic. Various modalities are used to treat the
hydrocele. Although hydrocelectomy is considered the gold stan-
dard technique, there has been renewed interest in cheaper alter-
natives like aspiration and sclerotherapy, which is less invasive, has
less morbidity and complications.1,2 A number of chemicals have
been described in the literature as sclerosants including tetracy-
cline,1 sodium tetradecyl sulphate(STDS),2 polidocanol,4 ﬁbrin
glue,5 phenol,6 OK-432,7 ethanolamine oleate,8 antazoline,9 rifam-
picin,10 and talc.10 The basic idea with sclerotherapy is to limit the/977 9842054327; fax: þ977
aniya).
ciates Ltd. Published by Elsevier Ltproduction of ﬂuid by instillation of a sclerosing solution into the
sac, which results in coaptation of the walls. However, the
outcomes are inconsistent because of lack of uniformity in method
and/or sclerosing agent used.2–10 Similarly up to date, very few
reported studies exist which compared hydrocelectomy with
aspiration and sclerotherapy. 2,3 We designed this study to compare
the two most popular methods in terms of safety, morbidity, total
cost, recurrence and patient satisfaction. We have chosen STDS as
the sclerosant for the study as it is cheap, readily available and has
been used safely and extensively.2
2. Materials and methods
A one year randomized controlled study included all symp-
tomatic adult males of unilateral primary vaginal hydrocele
(testicular hydrocele). Patients with fertility concerns or coexisting
scrotal haematocele, spermatocele or testicular malignancies were
excluded. Out of eighty-two patients who fulﬁlled the inclusion
criteria, 22 patients were unwilling to participate, therefore, sixty
patients between 15 and 75 years were studied.d. All rights reserved.
Table 1
Clinical proﬁle.
Open hydrocelectomy (n¼ 30) Aspiration-sclerotherapy (n¼ 30) p Value
Age (mean SD) (range) yrs 36.5 16 (15–66) 39 16.7 (15–75) 0.556
Duration in years (median) yrs 2.5 (0.25–30) 2.7 (0.25–16) 0.10
Hydrocele volume (mean SD) (range) ml 318.3 194.97 (50–1000) 219.6 186.47 (50–750) 0.13
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The diagnosis was conﬁrmed by ﬂuctuation and transillumination.
Laboratory investigations like hemoglobin, white blood cell count,
urine routine andmicroscopy examinationwere done in all and the
scrotal ultrasound was done when secondary pathologies like
testicular tumor or spermatocele had to be excluded.
Patients were divided into two groups of thirty patients each
with the help of computer generated random numbers; Group 1
underwent aspiration and sclerotherapy while Group 2 had open
hydrocelectomy. The procedures were done with aseptic precau-
tions in both the groups. The aspiration and sclerotherapywas done
in the outdoor ofﬁce for group 1 and patients in group 2 were
operated on Day Care Operation Theater. In group 1: aspiration of
the ﬂuid was done by a 16 gauze intravenous cannula attached to
a 50 ml syringe with a three way stopcock and the sclerosant
(sodium tetradecyl sulphate) was injected through the same
cannula in situ. The volume instilled was 50% of the aspirated ﬂuid
up to the maximum of 80 ml. The sclerosing solution was prepared
by diluting the mixture of 4 ml of 3% sodium tetradecyl sulphate
and 6 ml of 2% lignocaine hydrochloride with 70 ml of normal
saline. The concentration of sodium tetradecyl sulphate and
lignocaine hydrochloride in the solutionwas 0.15% each. In group 2,
Jaboulay’s procedure (eversion of tunica without excision of sac)
was performed under local anaesthesia and drain was not placed.
After the intervention, dry dressing with scrotal support was
applied for 24 h and oral NSAIDs (tablet combination of para-
cetamol 325 mg and ibuprofen 400 mg) was prescribed eight
hourly for 48 h, then after only on demand basis.
Patients were followed up at 48 h (T1), 1 week (T2), 1 month (T3),
3 months (T4) and 6 months (T5), when the incidence of fever, pain,
infection, ulceration, haematoma, and recurrence of the swelling
was noted. Fever was deﬁned as oral temperature more the 98.6 F
(Fahrenheit). Painwas assessed using visual analogue scale (VAS) of
10 (‘0’ meaning no pain at all and ‘10’ meaning worst possible pain),
and patient scoring 3 were considered to have pain. Infectionwas
deﬁned as the presence of either positive microbial culture from
wound discharge, or a combination of fever, pain, local erythema
and discharge at the incision site. Infection was managed with oral
antibiotics and daily dressings till thewound healed. The procedure
was repeated after 3 months if there was recurrence following
aspiration-sclerotherapy. The outcome was assessed in terms of
incidence of complications, total cost involved, loss of working
days, recurrence and satisfaction of the patients.
Each patient was asked if he was satisﬁed with the treatment.
The satisfaction was deﬁned if the following criteria were met:
decrease in size of hydrocele, relief of any hydrocele relatedTable 2
Complications and activity.
Complications Hydrocelectomy
(n¼ 30)
Aspiration-sclerotherapy
(n¼ 30)
p Value
Pain 25(83.3%) 21(70%) 0.22
Fever 8(26.7%) 2(6.7%) 0.03
Infection 4(14.3%) 0 0.03
Haematocele 1(3.3%) 1(3.3%) 1
Loss of working
days (mean SD)
7.07 3.95 1.13 1.25 0.001disability, and satisfaction with overall experience and results of
the procedure. The approximate cost involved was calculated by
addition of all investigations and operative charges, cost of drugs
and suture materials. We compared the loss of working days
separately and did not include it in the cost of therapy. The recur-
rence of hydrocele was deﬁned as the reaccumulation of percep-
tible scrotal ﬂuid with positive transillumination test requiring
reintervention after 3 months of procedure.
The collected data was entered in Microsoft excel programme
and analyzed by using SPSS 11.5 version. Student t test for differ-
ences in mean, Wilcoxan Ranksum test for differences in median,
and Chi square test for the parametric variables were applied as
appropriate. A p value of less than 0.05 was considered signiﬁcant.3. Results
There was no signiﬁcant difference between the two groups in
patients’ characteristics like age, duration of symptoms, size, and
number of hydroceles (Table 1). The median (interquartile range)
age of the patients was 33 years (25–51.7) and the median (range)
duration of symptoms before presentation to the hospital in the
study population was 2 (0.25–30) years.
There was no difference in the incidence of pain after the
intervention between the two groups. Eight patients (26.7%) in
group 2 developed fever while which was signiﬁcantly more
(p< 0.05) than 2 (6.7%) in group 1. Though, one patient (3.3%) in
each group developed haematocele after intervention, the one in
group 2 got further complicated and pyocele formed. Four (14%)
patients in group 2 developed superﬁcial surgical site infection
(p¼ 0.03). The loss of working days (mean SD) was 1.11.3 and
7.14.0 in groups 1 and 2 respectively (p< 0.001) (Table 2).
The cost of treatment (median) of hydrocele was NC Rs 300 (US$
4.3) and NC Rs 1527 (US$ 21.8) in the group 1 and 2 respectively
(p< 0.001) (1US$¼70NC Rs) (Table 3).
Nine patients (34.6%) in group 1 developed recurrence within 3
months. Out of those 9 patients who had undergone repeat aspi-
ration and sclerotherapy at 3 months, only 7 reported for follow up
at 6 months and all of them had recurrence. There was no signiﬁ-
cant difference in age, duration of symptoms and volume of aspi-
rated ﬂuid in the patients with and without recurrence after
aspiration and sclerotherapy (Table 4).
At 3 months follow up visit, 16 of 22 (61.5%) and 21 of 26 (95.5%)
patients (p¼ 0.005) and at 6 months, 13 of 20 (61.9%) and 19 of 21
(95%) patients (p¼ 0.01) of group 1 and 2, respectively, were
satisﬁed with the treatment (Fig. 1). The reasons of dissatisfactionTable 3
Cost.
Hydrocelectomy (n¼ 30) Sclerotherapy (n¼ 30) p Value
Investigation 100 (62–900) 110 (100–600) 0.39
Drugs 200 (100–2000) 240 (130–600) 0.49
Sutures 200 (120–500) – –
Operation 1000 (200–1000) – –
Total 1527 (715–4000) 300 (250–1200) 0.001
Values are expressed in median (range) (In NC) (1US$¼ 70 NC).
Table 4
Recurrence after sclerotherapy.
No recurrence
(n¼ 14)
With recurrence
(n¼ 7)
p Value
Age (mean SD) years 42.3 19.7 30 10.5 0.11
Duration (median) yrs 0.875 1.6 0.17
Volume (median) ml 125(50–550) 200(50–750) 0.54
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recurrence in 7 patients of group 1 and haematocele and pyocele
formation in one patient of group 2. One patient with recurrence in
group 1 underwent hydrocelectomy after one year and there was
no gross visible effect of the sclerotherapy at surgical exploration.
4. Discussion
The complications like fever and infection were minimal, loss of
working days and cost of therapy were less in aspiration and scle-
rotherapy. While there was no recurrence in hydrocelectomy, 34.6%
patients had recurrence after initial sclerotherapy and there was
no improvement in them even after repeat aspiration and scle-
rotherapy. More patients were satisﬁed with open hydrocelectomy
than aspiration and sclerotherapy and the major cause of dissatis-
faction after aspiration and sclerotherapywas recurrence of swelling.
Our patients presented at an earlier age (median 33 years) than
reported in western population.2,11 The reasons could be earlier
onset of the disease or only young patients are interested in seeking
medical advice perhaps due to fertility worries.
In our study, 25/30 (83.3%) patients had scrotal pain at 48 h of
hydrocelectomy which is similar to the ﬁnding of Shan and
coworkers, where 73.5% patients had postoperative pain.6 Twenty-
one of 30 (70%) patients complained of pain after 48 h of sclerosant
instillation which is comparable to Daehlin and coworkers obser-
vation where 18/22 (81.8%) patients had pain at one day after
instillation of tetracycline.4 However, Rencken and colleagues using
a combination of sodium tetradecyl sulphate and rolitetracycline
found pain only in 29% of the patients which is much lower than in
our study.12 This may be because of variation in tools used for
assessing pain. Fuse and colleagues have proposed addition of
lignocaine to sclerosant to avoid pain. However, two-third of our
patients had pain in spite of using the mixture of sclerosant and
lignocaine. An injection with local anesthetic into the cord beforePatient Satsifaction
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Fig. 1. Comparing satisﬁed patient in aspiration-sclerotherapy and hydrocelectomy
group.the treatment is probably a better option to decrease sclerosant
associated pain.13 The incidence of fever in our patients after
aspiration and sclerotherapy is 6.5% which is comparable to the
ﬁndings of Fracchia and coworkers who reported fever in 3/47 (6%)
patients after sclerotherapy with the same agent.11 The cause of
fever is attributed to inﬂammatory reaction in the emptied tunica
sac and we used anti-inﬂammatory agent only on demand. The
mean loss of working days in our patients was 1.13 after scle-
rotherapy which is comparable to the report of Roosen and
coworkers where 19 of 20 (95%) patients resumed normal activity
within 24 h of therapy.9 Fracchia and coworkers have reported that
94% patients resumed normal activity within 72 h of the scle-
rotherapy.11 We found that the loss of working days in hydro-
celectomy was seven times more than in sclerotherapy.
We found that the total cost of hydrocelectomy was three times
more than sclerotherapy. But, this difference in the cost involved is
three times less than in the west, which may be because of less
operation cost, cheaper sutures and drugs in our hospital.2,11
In our study, 61.9% of patients had no recurrence after the single
injection which is comparable to the reported cure rate of 64% by
Rencken and coworkers,12 but much less than 75%–88% success
rate of other studies.2,14 However, the comparison has to be made
with caution as the deﬁnition of terms like ‘success’ and ‘cure’ are
author dependent and variable. All of our patients undergoing
repeat aspiration and sclerotherapy developed recurrence, sup-
porting the observation that only a marginal improvement is
achieved on success rate by repeating the treatment session.2,11
However, there are also condictory reports of improvement in
success rates by 32–44% with multiple sessions of aspiration and
sclerotherapy.12,15
We have used more concentrated and smaller volume of scle-
rosing solution as suggested by Beiko and coworkers, but the
success rate has not improved.2 It has been reported that larger
hydrocele has a greater chance of recurrence after initial scle-
rotherapy.15 However; we found no signiﬁcant difference in the
median amount of ﬂuid, duration of symptoms in patients with and
without recurrence of hydrocele (p¼ 0.54) (Table 4).
In our study, 16/22 (62%) patients were satisﬁed with aspiration
and sclerotherapy which is comparable to the of other reports.2,11 It
is interesting to ﬁnd Stattin and coworkers have report of high
satisfaction rate (95%) with aspiration and sclerotherapy with the
same agent.13 It is noteworthy that only one patient of hydro-
celectomy who had developed haematocele and later pyocele was
unsatisﬁed with the therapy. Beiko and coworkers have also
reported high satisfaction rate (88%) with hydrocelectomy.2
We feel that inadequate sessions of repeat aspiration, shorter
time interval between the initial and repeat aspirations, dilution of
the sclerosing agent, subclinical ﬁlarial infection and inadequate
temperature maintenance during storage of sclerosing agent may
have resulted in lower success rate with sclerotherapy in our
patients. However, this needs to be explored.5. Conclusion
Even though the postoperative complications, morbidity and
total expenditure were less; the recurrence rate and the patient
satisfaction were not desirable in aspiration and sclerotherapy.
Therefore, aspiration and sclerotherapy can be considered as an
alternative option where resources for surgery are limited and
hydrocelectomy should remain as the gold standard modality for
the treatment of hydrocele.
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